Liposomal cytarabine for central nervous system embryonal tumors in children and young adults

Journal of Neuro-Oncology

Volumn 103, Issue 3, 2011, Pages 561-566

  Partap, Sonia ^a   Murphy, Patricia A ^a   Vogel, Hannes ^b   Barnes, Patrick D ^c   Edwards, Michael S B ^c   Fisher, Paul G ^a,c  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c STANFORD UNIVERSITY   (United States)

Author keywords

Brain tumor; Central nervous system; Childhood; Embryonal tumor; Liposomal cytarabine; Medulloblastoma

Indexed keywords

CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; ETOPOSIDE; LIPOSOME; LOMUSTINE; OXALIPLATIN; VINCRISTINE;

ADOLESCENT; ADULT; ARACHNOIDITIS; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER REGRESSION; CANCER RELAPSE; CANCER SURVIVAL; CEREBROSPINAL FLUID CYTOLOGY; CHILD; CLINICAL ARTICLE; DRUG INDUCED HEADACHE; DRUG TOLERABILITY; FEMALE; HIGH RISK PATIENT; HUMAN; INFANT; MALE; MEDULLOBLASTOMA; MENINGEAL METASTASIS; NEUROECTODERM TUMOR; NEUROENDOCRINE TUMOR; OVERALL SURVIVAL; RETROSPECTIVE STUDY; RHABDOID TUMOR; SURVIVAL TIME; TERATOMA;

ADOLESCENT; ADULT; ANTIMETABOLITES, ANTINEOPLASTIC; CENTRAL NERVOUS SYSTEM NEOPLASMS; CHILD; CHILD, PRESCHOOL; CYTARABINE; FEMALE; HUMANS; INFANT; KAPLAN-MEIER ESTIMATE; LIPOSOMES; MAGNETIC RESONANCE IMAGING; MALE; NEOPLASMS, GERM CELL AND EMBRYONAL; YOUNG ADULT;

EID: 79959794977     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-010-0419-y     Document Type: Article

References (22)

1. Gurney JG, Smith MA, Bunin GR (1999) CNS and miscellaneous intracranial and intraspinal neoplasms. In: Ries LAG, Smith MA, Gurney JG et al (eds) Cancer Incidence and Survival Among children and Adolescents: United States SEER Program 1975-1995, National Cancer Institute, SEER Program. NIH Pub. No. 99-4649, Bethesda, MD
2. Blaney SM, Boyett J, Friedman H, Gajjar A, Geyer R, HorowtizM et al (2005) Phase I clinical trial of mafosfamide in infants and children aged 3 years or younger with newly diagnosed embryonal tumors: a pediatric brain tumor consortium study (PBTC-001). J Clin Oncol 23(3):525-531 (Pubitemid 46224229)
3. Shapiro WR, Young DF, Mehta BM (1975) Methotrexate: distribution in cerebrospinal fluid after intravenous, ventricular, and lumbar injections. N Engl J Med 293(4):161-166
4. Strong JM, Collins JM, Lester C, Poplack DG (1986) Pharmacokinetics of intraventricular and intravenous N,N′,N″- triethylenethiophosphoramide (thiotepa) in rhesus monkey and humans. Cancer Res 46(12 Pt 1):6101-6104 (Pubitemid 17221737)
5. Zimm S, Collins JM, Miser J, Chatterji D, Poplack DG (1984) Cytosine arabinoside cerebrospinal fluid kinetics. Clin Pharmacol Ther 35(6):826-830 (Pubitemid 14077491)
6. Kim S, Chatelut E, Kim JC, Howell SB, Cates C, Kormanik PA et al (1993) Extended CSF cytarabine exposure following intrathecal administration of DTC 101. J Clin Oncol 11(11):2186-2193 (Pubitemid 23332256)
7. Glantz MJ, LaFollette S, Jaeckle KA, Shapiro W, Swinnen L, Rozental JR et al (1999) Randomized trial of slow-release versus a standard formulation of cytarabine for the intrathecal treatment of lymphomatous meningitis. J Clin Oncol 17(10):3110-3116 (Pubitemid 29470639)
8. Glantz MJ, Jaeckle KA, Chamberlain MC, Phuphanich S, Recht L, Swinnen LJ et al (1999) A randomized controlled trial comparing intrathecal sustained-release cytarabine (Depocyt) to intrathecal methotrexate in patients with neoplastic meningitis from solid tumors. Clin Cancer Res 5(11):3394-3402
9. Cole BF, Glantz MJ, Jaeckle KA, Chamberlain MC, Mackowiak JI (2003) Quality-of-life-adjusted survival comparison of sustained- release cytosine arabinoside versus intrathecal methotrexate for treatment of solid tumor neoplastic meningitis. Cancer 97(12):3053-3060 (Pubitemid 36676260)
10. Lassaletta A, Perez-Olleros P, Scaglione C, Sirvent S, De Prada I, Perez-Martinez A et al (2007) Successful treatment of intracranial ependymoma with leptomeningeal spread with systemic chemotherapy and intrathecal liposomal cytarabine in a two-year-old child. J Neurooncol 83(3):303-306 (Pubitemid 46952242)
11. Chamberlain MC, Glantz MJ (2008) Sequential salvage chemotherapy for recurrent intracranial hemangiopericytoma. Neurosurgery 63(4):720-727
12. Bomgaars L, Geyer JR, Franklin J, Dahl G, Park J, Winick NJ et al (2004) Phase I trial of intrathecal liposomal cytarabine in children with neoplastic meningitis. J Clin Oncol 22(19): 3916-3921 (Pubitemid 41079873)
13. Benesch M, Siegler N, Hoff K, Lassay L, Kropshofer G, Müller H et al (2009) Safety and toxicity of intrathecal liposomal cytarabine (Depocyte) in children and adolescents with recurrent or refractory brain tumors: a multi-institutional retrospective study. Anticancer Drugs 20(9):794-799
14. Grossman SA, Finkelstein DM, Ruckdeschel JC, Trump DL, Moynihan T, Ettinger DS (1993) Randomized prospective comparison of intraventricular methotrexate and thiotepa in patients with previously untreated neoplastic meningitis. J Clin Oncol 11(3):561-569 (Pubitemid 23071056)
15. Fisher PG, Kadan-Lottick NS, Korones DN (2007) Intrathecal thiotepa: reappraisal of an established therapy. J Pediatr Hematol Oncol 24(4):274-278
16. Blaney SM, Heideman R, Berg S, Adamson P, Gillespie A, Geyer JR et al (2003) Phase I clinical trial of intrathecal topotecan in patients with neoplastic meningitis. J Clin Oncol 21(1):143-147
17. Groves MD, Glantz MJ, Chamberlain MC, Baumgartner KE, Conrad CA, Hsu S et al (2008) A multicenter phase II trial of intrathecal topotecan in patients with meningeal malignancies. Neuro-Oncol 10(2):208-215
18. Bernardi RJ, Bomgaars L, Fox E, Balis FM, Egorin MJ, Lagattuta TF et al (2008) Phase I clinical trial of intrathecal gemcitabine in patients with neoplastic meningitis. Cancer Chemother Pharmacol 62(2):355-361 (Pubitemid 351692082)
19. Blaney SM, Balis FM, Berg S, Arndt CA, Heideman R, Geyer JR et al (2005) Intrathecal mafosfamide: a preclinical pharmacology and phase I trial. J Clin Oncol 23(7):1555-1563
20. Gururangan S, Petros WP, Poussaint TY, Hancock ML, Phillips PC, Friedman HS et al (2006) Phase I trial of intrathecal spartaject busulfan in children with neoplastic meningitis: a Pediatric Brain Tumor Consortium Study (PBTC-004). Clin Cancer Res 12(5):1540-1546
21. Lassaletta A, Lopez-Ibor B, Mateos E, Gonzalez-Vicent M, Perez-Martinez A, Sevilla J et al (2009) Intrathecal liposomal cytarabine in children under 4 years with malignant brain tumors. J Neurooncol 95(1):65-69
22. Pui C (2007) Toward optimal use of intrathecal liposomal cytarabine. Leuk Lymphoma 48(9):1672-1673